LFCR Lifecore: Bathi resik saben saham sajrone patang kuartal pungkasan

The visual price representation available on the GURU.Markets platform demonstrates the EPS (TTM) dynamics for Lifecore Biomedical (LFCR), which currently stands at -432.10. The Lifecore Biomedical (LFCR) business relies on the implementation of AI and robotics in biopharmaceutical production to reduce costs. While geopolitical conflicts and sanctions hinder the international import of raw materials, the company's unique sterile injectable manufacturing capacities protect Lifecore Biomedical (LFCR) from aggressive pricing pressure from competitors.

LFCR (Lifecore Biomedical Inc.) riwayat Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 13.11.2026

Lifecore - rincian analitis lan metrik utama (LFCR)

- rega lan prakiraan konsensus rega:

Rega bursa Lifecore Biomedical|LFCR - Bagan rega target

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Lifecore Biomedical Inc.|LFCR - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator nilai buku ekuitas:

Rega Buku Saham Lifecore Biomedical|LFCR - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku lifecore.com|LFCR - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Utang marang Ekuitas Lifecore Biomedical|LFCR - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Lifecore Biomedical|LFCR - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Lifecore Biomedical Inc.|LFCR - Utang jangka dawa perusahaan|Utang jangka cendhak Lifecore Biomedical|Indikator likuiditas cepet lifecore.com

- indikator pendapatan resik lan kelipatan nilai:

LFCR - Bathi resik perusahaan|Bathi resik sing dikarepake Lifecore Biomedical|LFCR - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Lifecore Biomedical|LFCR - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lifecore Biomedical Inc.|LFCR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Lifecore Biomedical|LFCR - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan lifecore.com|LFCR - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lifecore Biomedical

Pambiji fundamental perusahaan:Lifecore Biomedical, Inc.

Barang unggulan Lifecore Biomedical, Inc.

For Lifecore Biomedical (LFCR), this indicator reflects the monetization efficiency of its unique CDMO capacities within the injectables segment. The 12-month EPS annual growth rate is calculated as the percentage change in earnings per share over the last four quarters relative to the same period last year. The growth of this metric confirms the company's ability to convert strict FDA standards into financial results. The stability of this figure underscores the high switching costs for customers moving to other manufacturers.

Analisis pesaing Lifecore Biomedical